Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CIPROFLOXACIN EXTENDED RELEASE

CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Standard Dose
212.6MG;EQ 287.5MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CIPROFLOXACIN EXTENDED RELEASE is listed in Drugs@FDA under application 078712 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 212.6MG;EQ 287.5MG BASE Sponsor FOSUN PHARMA Submission history Latest submission status date: 2024-09-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview CIPROFLOXACIN EXTENDED RELEASE is listed in Drugs@FDA under application 078712 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 212.6MG;EQ 287.5MG BASE Sponsor FOSUN PHARMA Submission history Latest submission status date: 2024-09-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.